In HBV associated HCC, HBV replicating cells displayed resistance to cisplatin and sorafenib via activated Wnt signaling through EpCAM, and exhibited increased expression of stemness-related markers (CD44, CD133, NANOG, OCT4, and SOX2) [21]. Here, EPCAM is linked to hepatocellular carcinoma.